High efficiency DNA delivery into swine oocytes and embryos by electronic pulse delivery (EPD)

Cell Research

Volumn 7, Issue 1, 1997, Pages 39-49

  Yang, Yang ^a,b   Huang, Shao Hua ^a   Zhao, Xi ^a  

^a Cell Biosciences Inc   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

DNA transfer; Electronic pulse delivery (EPD); Swine embryos; Transgenic pig; Xenotransplantation

Indexed keywords

MAMMALIA; SUS SCROFA;

CD59 ANTIGEN; DNA; H 2K(K) ANTIGEN; H-2K(K) ANTIGEN; H2 ANTIGEN;

ANIMAL; ARTICLE; EMBRYO; GENE TRANSFER; GENETICS; HUMAN; OOCYTE; PRENATAL DEVELOPMENT; PROMOTER REGION; SWINE; TRANSGENE; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD59; DNA; EMBRYO; EMBRYONIC AND FETAL DEVELOPMENT; GENE TRANSFER TECHNIQUES; H-2 ANTIGENS; HUMANS; OOCYTES; PROMOTER REGIONS (GENETICS); SWINE; TRANSGENES;

EID: 0031156055     PISSN: 10010602     EISSN: None     Source Type: Journal    
DOI: 10.1038/cr.1997.5     Document Type: Article

References (17)

1. Cozzi E, White DJ. The generation of transgenic pigs as potential organ donors for humans. Nat Med 1995; 1 (9):964-6.
2. Michaels MG, Simmons RL. Xenotransplant-associated zoonoses. Strategies for prevention. Transplantation 1994; 57 (1):1-7.
3. Ye Y, Niekrasz M, Kosanke S, et al. The pig as a potential organ donor for man. A study of potentially transferable disease from donor pig to recipient man. Transplantation 1994; 57 (5):694-703.
4. Michaels MG, McMichael JP, Brasky K, et al. Screening donors for xenotransplantation. The potential for xenozoonoses. Transplantation 1994; 57 (10):1462-5.
5. Sandrin MS, McKenzie IF. Gal alpha (1,3)Gal, the major xenoantigen(s) recognized in pigs by human natural antibodies. Immunol Rev 1994; 141:169-90.
6. Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Potential for prevention of xenograft hyperacute rejection. Transplantation 1991; 52 (3):530-3.
7. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacute organ rejection. Proc Natl Acad Sci USA 1994; 91 (23):11153-7.
8. Ryan US. Complement inhibitory therapeutics and xenotransplantation. Nat Med 1995; 1 (9):967-8.
9. Mullins JJ, Mullins LJ. Transgenesis in nonmurine species. Hypertension 1993; 22 (4):630-3.
10. Janne J, Hyttinen JM, Peura T, et al. Transgenic bioreactors. Int J Biochem 1994; 26 (7):859-70.
11. Wall RJ, Pursel VG, Hammer RE, Brinster RL. Development of porcine ova that were centrifuged to permit visualization of pronuclei and nuclei. Biol Reprod 1985; 32 (3):645-51.
12. Zhao X. EPD, a novel technology for drug delivery. Advanced Drug Delivery reviews 1995; 17:257-62.
13. Zhao X. The Appylication of Electroic Pulse Delivery in Gene Therapy: progress and perspectives. In: Feigner PL, heller MJ, Lehn P, Behr JP, Szoka FC. eds. Artificial Self-Assembling Systems for gene Delivery. The American Chemical Society 1996: 64-71.
14. Zhao X, Zhang PJ, Wong TK. Application of Baekonization: A new approach to produce transgenic fish. Molecular Marine Biology and Biotechnology 1993; 2: 63-69.
15. Zhao X, Wong, TK. Production of transgenics by electronic pulse delivery. J Cell Biology 1991; 115:83.
16. Langford GA, Yannoutsos N, Cozzi E, et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc 1994; 26 (3):1400-1.
17. Rosengard AM, Cary NR, Langford GA, Tucker AW, Wallwork J, White DJ. Tissue expression of human complement inhibitor, decay-accelerating factor, in transgenic pigs. A potential approach for preventing xenograft rejection. Transplantation 1995; 59 (9):1325-33.